• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Bausch + Lomb supports pediatric outreach event

Article

Boston Foundation for Sight (BFS) has received a $15,000 charitable donation from Bausch + Lomb (B + L) to support Stevens-Johnson Syndrome (SJS) Kids Week 2012.

Needham, MA-Boston Foundation for Sight (BFS) has received a $15,000 charitable donation from Bausch + Lomb (B + L) to support Stevens-Johnson Syndrome (SJS) Kids Week 2012.

SJS Kids Week is an annual outreach event for pediatric SJS survivors and their families. The founder of SJS Kids Week, Lynette Johns, OD, envisioned a special week where families from all over the world could live together and receive emotional support and sight-saving treatment.

“We are so thrilled with this generous charitable donation,” said Dr. Johns. “This is the latest in a long history of financial support from B + L, and we are very grateful that they have chosen to sponsor SJS Kids Week again this year.”

An intense immune reaction to medications or infections, SJS can cause severe burn-like lesions on the skin, organs, and mucous membranes, including the eyes.

BFS is a nonprofit eye health-care organization with a mission to improve the quality of life for patients and their families by transforming the understanding, treatment, and care of complex corneal disease. For more information, visit www.bostonsight.org.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.